DeepMind COO Lila Ibrahim discusses building powerful AI with care, ethics and a long-term focus on human impact.
Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
When it comes to the latest technologies, utilities aren’t exactly early adopters—with good reason. Silicon Valley’s motto of ...
Morning Overview on MSN
Terrifying lifelike humanoid robot with muscles and bones just woke up
The latest viral clip of a faceless android twitching under its own power has pushed humanoid robotics into a new, unsettling ...
Over time, ‘vibe coding’ will simply become ‘ coding ’. The software development lifecycle (SDLC) will increasingly include ...
New research suggests that motivation acts less like a volume knob for effort and more like a camera lens that changes how ...
This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim ...
Introduction Demographic change is resulting in a growing number of individuals requiring nursing care, while the ...
Based on the literature synthesis and system mapping presented in Section 2.4, a set of design requirements (DRs) was derived ...
In the draft guidance, the agency discusses how sponsors can leverage MRD and complete response rates as near-term efficacy measures and speed new therapies to market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results